What Investors Should Know About a $24 Million Device Exit
A notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
Kick off an IRA with zero-commission index funds, focusing on cost-effective options and straightforward fund selection.
17,502 articlesA notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
A crisis-focused charity is pivoting to support TSA officers unpaid during a partial government shutdown. The effort ...
The Supreme Court looks poised to restrict late mail ballots, a move that could impact voter turnout and state electi...
JPMorgan's revised target to $134 underscores a brighter backdrop for Bunge as the Viterra deal closes and 2026 biofu...
A California federal court weighs a landmark supply-chain risk dispute between Anthropic and the Department of War, w...
Iran publicly spurns ceasefire talks amid renewed attacks, while the White House insists talks continue. The flare-up...
VFVA has posted solid gains by targeting cheap U.S. equities, but a hidden volatility risk lies in its deep value app...
Anchorage Digital announces a historic custody milestone, expanding regulated access to Tron assets for institutional...
PennantPark Investment’s hefty yield hinges on a reserve that funds part of its payouts and a portfolio heavy in floa...
Scotiabank boosted Cameco's price target to $175 as a global push for nuclear power gains traction and a new supply d...
A wave of weaker confidence is reshaping housing activity, even as the job market holds steady. This guide breaks dow...
Barclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...